JP2012508693A - 睡眠中の鼾および呼吸努力関連覚醒のための薬および処置 - Google Patents

睡眠中の鼾および呼吸努力関連覚醒のための薬および処置 Download PDF

Info

Publication number
JP2012508693A
JP2012508693A JP2011535836A JP2011535836A JP2012508693A JP 2012508693 A JP2012508693 A JP 2012508693A JP 2011535836 A JP2011535836 A JP 2011535836A JP 2011535836 A JP2011535836 A JP 2011535836A JP 2012508693 A JP2012508693 A JP 2012508693A
Authority
JP
Japan
Prior art keywords
subject
aureus
sleep
colonization
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011535836A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012508693A5 (enExample
Inventor
フィリップ・コマンズ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2008905902A external-priority patent/AU2008905902A0/en
Application filed by Individual filed Critical Individual
Publication of JP2012508693A publication Critical patent/JP2012508693A/ja
Publication of JP2012508693A5 publication Critical patent/JP2012508693A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/07—Bacillus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Otolaryngology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2011535836A 2008-11-13 2009-11-09 睡眠中の鼾および呼吸努力関連覚醒のための薬および処置 Pending JP2012508693A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2008905902 2008-11-13
AU2008905902A AU2008905902A0 (en) 2008-11-13 Treatment for snoring and respiratory effort related arousals in sleep
PCT/AU2009/001451 WO2010054424A1 (en) 2008-11-13 2009-11-09 Agents and treatment for snoring and respiratory effort related arousals in sleep

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015133482A Division JP2015180689A (ja) 2008-11-13 2015-07-02 睡眠中の鼾および呼吸努力関連覚醒のための薬および処置

Publications (2)

Publication Number Publication Date
JP2012508693A true JP2012508693A (ja) 2012-04-12
JP2012508693A5 JP2012508693A5 (enExample) 2012-12-27

Family

ID=42169525

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011535836A Pending JP2012508693A (ja) 2008-11-13 2009-11-09 睡眠中の鼾および呼吸努力関連覚醒のための薬および処置
JP2015133482A Pending JP2015180689A (ja) 2008-11-13 2015-07-02 睡眠中の鼾および呼吸努力関連覚醒のための薬および処置

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015133482A Pending JP2015180689A (ja) 2008-11-13 2015-07-02 睡眠中の鼾および呼吸努力関連覚醒のための薬および処置

Country Status (8)

Country Link
US (1) US20110311588A1 (enExample)
EP (1) EP2358385A4 (enExample)
JP (2) JP2012508693A (enExample)
KR (1) KR20110112803A (enExample)
CN (1) CN102281894A (enExample)
AU (1) AU2009316226B2 (enExample)
CA (1) CA2743649A1 (enExample)
WO (1) WO2010054424A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10022083B2 (en) 2011-06-02 2018-07-17 Abdulmohsen E. A. H. Al-Terki Multiple oral and nasal surgical procedures method and kit
US8387798B1 (en) 2012-04-27 2013-03-05 Abdulmohsen E. A. H. Al-Terki Mutiple oral and nasal surgical procedures method and kit
US11406671B2 (en) 2015-04-24 2022-08-09 The Translational Genomics Research Institute Compositions and methods for augmenting the nasal microbiome
CN113943679B (zh) * 2021-11-08 2023-02-03 南京农业大学 一株羊鼻腔源贝莱斯芽孢杆菌及其应用
CN115644136B (zh) * 2022-11-11 2025-07-29 河南省人民医院 一种用于阻塞性呼吸睡眠暂停综合征的微生态动物模型

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5980908A (en) * 1991-12-05 1999-11-09 Alfa Laval Ab Bacterial cell surface protein with fibronectin, fibrinogen, collagen and laminin binding ability, process for the manufacture of the protein and prophylactic treatment
SE9604844D0 (sv) * 1996-12-30 1996-12-30 Carl Gerhard Gottfries Medel för terapeutisk behandling av fibromyalgi och kroniskt trötthetssyndrom

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
JPN6014000758; Ｐｒｏｃｅｅｄｉｎｇｓ　ｏｆ　ｔｈｅ　Ｎａｔｉｏｎａｌ　Ａｃａｄｅｍｙ　ｏｆ　Ｓｃｉｅｎｃｅｓ　ｏｆ　ｔｈｅ　Ｕｎｉｔｅｄ　Ｓｔａｔｅｓ　ｏｆ　Ａｍｅｒｉｃａ Ｖｏｌ．１０３，　Ｎｏ．４５, 2006, ｐ．１６９４２-１６９４７ *
JPN6014000761; Ｉｎｆｅｃｔｉｏｎ　ａｎｄ　Ｉｍｍｕｎｉｔｙ Ｖｏｌ．７４，　Ｎｏ．４, 2006, ｐ．２１４５-２１５３ *
JPN6014000763; 臨床検査 Ｖｏｌ．４４，　Ｎｏ．５, 2000, ｐ．５３９-５４２ *
JPN6014000764; 感染症学雑誌 Ｖｏｌ．８０，　Ｎｏ．１, 2006, ｐ．１３-１８ *
JPN6014000768; 化学療法の領域 Ｖｏｌ．５，　Ｎｏ．１, 1990, ｐ．１２２-１３０ *
JPN6014000771; 化学療法の領域 Ｖｏｌ．６，　Ｎｏ．３, 1990, ｐ．４７５-４８２ *
JPN6014000773; 医薬ジャーナル Ｖｏｌ．２７，　Ｎｏ．１０, 1991, ｐ．２１０１-２１０７ *
JPN6014000776; 社会医学研究 Ｎｏ．２０, 2002, ｐ．４７-４９ *
JPN6014000779; 耳鼻臨床 Ｖｏｌ．８３，　Ｎｏ．４, 1990, ｐ．５１３-５１９ *

Also Published As

Publication number Publication date
KR20110112803A (ko) 2011-10-13
EP2358385A1 (en) 2011-08-24
EP2358385A4 (en) 2013-08-14
AU2009316226B2 (en) 2015-08-13
AU2009316226A1 (en) 2010-05-20
US20110311588A1 (en) 2011-12-22
CA2743649A1 (en) 2010-05-20
CN102281894A (zh) 2011-12-14
JP2015180689A (ja) 2015-10-15
WO2010054424A1 (en) 2010-05-20

Similar Documents

Publication Publication Date Title
Roudsari et al. Health effects of probiotics on the skin
JP6505594B2 (ja) プロバイオティクス細菌
JP2003535903A (ja) プロバイオティックを用いた、粘膜表面での細菌またはウイルス感染の免疫療法または治療、およびそのための組成物
Charng et al. Inhibition of allergen-induced airway inflammation and hyperreactivity by recombinant lactic-acid bacteria
TW200305370A (en) Vital cell preparations containing lactic acid bacterium as the active ingredient and lactic acid bacterium-containing foods
JP2015180689A (ja) 睡眠中の鼾および呼吸努力関連覚醒のための薬および処置
JP2022504792A (ja) 炎症性疾患及び関連する感染の治療方法
US11801275B2 (en) Compositions and methods for common colds
Yoshida et al. Clinical effects of probiotic Bifidobacterium breve supplementation in adult patients with atopic dermatitis
CN118146972B (zh) 一种改善口腔健康的瑞士乳杆菌及益生菌组合物
Anilkumar et al. Role of friendly bacteria in oral health-a short review.
Susanti et al. Asthma clinical improvement and reduction in the number of CD4 CD25 foxp3 Treg and CD4 IL-10 cells after administration of immunotherapy house dust mite and adjuvant probiotics and/or Nigella Sativa powder in mild asthmatic children
JP2007169200A (ja) インフルエンザ感染予防のための医薬及び飲食品
John et al. Otitis media among high-risk populations: can probiotics inhibit Streptococcus pneumoniae colonisation and the risk of disease?
CN113041266B (zh) 一株改善银屑病样小鼠病理特征的干酪乳杆菌及其应用
US6767537B2 (en) Composition and method for the treatment of sinusitis
KR20230041964A (ko) 박테리아 균주를 포함하는 조성물 및 눈 질환과 병변을 치료하기 위한 그 용도
EP3015109B1 (en) Biological barrier with simethicone for the use in the treatment of naso-pharyngo-tubal infections
US20250302889A1 (en) Ingestible Nutritive Compositions With Prebiotics, Probiotics, and Postbiotics
López-Martín et al. Prospective observational cohort study of the efficacy of bacterial immune prophylaxis in the prevention of uncomplicated, recurrent urinary tract infections
Asan et al. Effect of probiotics on oral Candida-a review
US11020440B2 (en) Probiotic for the treatment of psoriasis
CN119752686A (zh) 一株可缓解及预防变应性鼻炎的长双歧杆菌婴儿亚种及其应用
Reid Extra intestinal effects of prebiotics and probiotics
Drago et al. Probiotics: a new therapeutic approach in the treatment of allergy and eczema.

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121109

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20121109

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140114

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140414

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140421

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140714

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20150302